UMIFENOVIR: 190 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
190
Total FAERS Reports
19 (10.0%)
Deaths Reported
33
Hospitalizations
190
As Primary/Secondary Suspect
6
Life-Threatening
First Report: 2020 · Latest Report: 20241101
What Are the Most Common UMIFENOVIR Side Effects?
#1 Most Reported
Off label use
119 reports (62.6%)
#2 Most Reported
Product use in unapproved indication
29 reports (15.3%)
#3 Most Reported
Product use issue
18 reports (9.5%)
All UMIFENOVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 119 | 62.6% | 8 | 18 |
| Product use in unapproved indication | 29 | 15.3% | 5 | 1 |
| Diarrhoea | 18 | 9.5% | 2 | 0 |
| Product use issue | 18 | 9.5% | 0 | 1 |
| Vomiting | 13 | 6.8% | 0 | 0 |
| Respiratory failure | 12 | 6.3% | 8 | 0 |
| Dyspnoea | 9 | 4.7% | 0 | 1 |
| Multiple organ dysfunction syndrome | 9 | 4.7% | 9 | 1 |
| Acute respiratory distress syndrome | 8 | 4.2% | 3 | 3 |
| Nausea | 8 | 4.2% | 0 | 0 |
| Pyrexia | 8 | 4.2% | 0 | 0 |
| Drug ineffective | 7 | 3.7% | 3 | 3 |
| Pneumonia | 7 | 3.7% | 0 | 1 |
| Acute kidney injury | 6 | 3.2% | 1 | 5 |
| Fibrin d dimer increased | 6 | 3.2% | 0 | 1 |
| Liver injury | 6 | 3.2% | 0 | 4 |
| Anosmia | 5 | 2.6% | 0 | 0 |
| Condition aggravated | 5 | 2.6% | 1 | 1 |
| Covid-19 | 5 | 2.6% | 1 | 5 |
| Leukopenia | 5 | 2.6% | 0 | 0 |
Who Reports UMIFENOVIR Side Effects? Age & Gender Data
Gender: 48.4% female, 51.6% male. Average age: 51.0 years. Most reports from: CN. View detailed demographics →
Is UMIFENOVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2020 | 68 | 4 | 13 |
| 2021 | 1 | 0 | 0 |
| 2022 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 1 |
What Is UMIFENOVIR Used For?
| Indication | Reports |
|---|---|
| Covid-19 | 134 |
| Covid-19 pneumonia | 17 |
| Antiviral treatment | 9 |
| Product used for unknown indication | 6 |
UMIFENOVIR vs Alternatives: Which Is Safer?
UMIFENOVIR vs UNSPECIFIED INGREDIENT
UMIFENOVIR vs UPADACITINIB
UMIFENOVIR vs URAPIDIL
UMIFENOVIR vs UREA
UMIFENOVIR vs URIDINE TRIACETATE
UMIFENOVIR vs UROFOLLITROPIN
UMIFENOVIR vs URSODIOL
UMIFENOVIR vs USTEKINUMAB
UMIFENOVIR vs USTEKINUMAB-STBA
UMIFENOVIR vs VADADUSTAT
Official FDA Label for UMIFENOVIR
Official prescribing information from the FDA-approved drug label.